Cerecor Inc(NASDAQ:CERC) 
Cerecor Inc., a biopharmaceutical company, focuses on development and commercialization of treatments for rare and orphan diseases. The company develops monosaccharide therapies for the treatment of congenital disorders of glycosylation, such as CERC-801, CERC-802, and CERC-803. It is also involved ...
Website: http://www.cerecor.com
Founded: 2011
Full Time Employees: 30 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-12
P
O 12.51
H 12.51
L 11.74
C 12.16
V 2,442
10EMA 12.16
20EMA 12.16
60EMA 12.16
120EMA 12.16
250EMA 12.16